BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16526056)

  • 21. The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma.
    Schrier BP; Vriesema JL; Witjes JA; Kiemeney LA; Schalken JA
    Eur Urol; 2006 Jul; 50(1):76-82. PubMed ID: 16413663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study.
    Huang CS; Ho WL; Lee WS; Sheu MT; Wang YJ; Tu SH; Chen RJ; Chu JS; Chen LC; Lee CH; Tseng H; Ho YS; Wu CH
    Biochem Pharmacol; 2008 May; 75(9):1783-96. PubMed ID: 18355800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia.
    Koomägi R; Sauerbrey A; Zintl F; Volm M
    Anticancer Res; 1998; 18(6A):4307-9. PubMed ID: 9891483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia].
    Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K
    Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
    Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
    Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.
    Ekberg J; Holm C; Jalili S; Richter J; Anagnostaki L; Landberg G; Persson JL
    Eur J Haematol; 2005 Aug; 75(2):106-15. PubMed ID: 16004607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy.
    Lu M; Fei M; Cheng C; Wang Y; He S; Zhao Y; Gao S; Ke Q; Li P; Cui X; Shen A
    Arch Med Res; 2008 Aug; 39(6):573-81. PubMed ID: 18662588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
    Rüster C; Bondeva T; Franke S; Förster M; Wolf G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic potential of bone marrow cyclin E and P27, in Egyptian patients with acute myeloid leukemia.
    Abdel Alim A; Youssef SR; Farouk HM
    Egypt J Immunol; 2010; 17(1):9-18. PubMed ID: 22053605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
    Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL
    Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.
    Melo MB; Ahmad NN; Lima CS; Pagnano KB; Bordin S; Lorand-Metze I; SaAd ST; Costa FF
    Hematology; 2002 Feb; 7(1):13-9. PubMed ID: 12171773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
    Sun X; Zhang HW; Zhang ZR
    J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 induction of cellular migration requires p27(KIP1).
    Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
    Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.